Inventor
Yvo Graus
Inventor
Odijk, NL
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides25%
A61KPreparations for medical, dental or toiletry purposes14%
C12NMicroorganisms or enzymes13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation3%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
9,187,565'Antibodies against CD38 for treatment of multiple myeloma'20159,181,344'Use of effector-function-deficient antibodies for treatment of auto-immune diseases'20159,102,733'Anti-OX40L antibodies'20159,040,050'Combination treatment of CD38-expressing tumors'2015RE044389'Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies'2013RE044359'Nucleic acid molecules encoding anti-P-selectin antibodies'2013RE043568'Anti-P-selectin antibodies'20127,868,141'Anti-OX40L antibodies'20117,850,962'Human monoclonal antibodies against CD20'20107,829,673'Antibodies against CD38 for treatment of multiple myeloma'20107,824,684'Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies'20107,807,158'Antibodies against IL-13 receptor alpha1 and uses thereof'20107,754,867'Nucleic acid molecules encoding anti-P-selectin antibodies'20107,579,157'Antibody selection method against IGF-IR'20097,572,897'Antibodies against insulin-like growth factor I receptor and uses thereof'20097,563,441'Anti-P-selectin antibodies'20097,501,496'Anti-OX40L antibodies'20097,378,503'Antibodies against insulin-like growth factor 1 receptor and uses thereof'20087,288,271'Chlorogenic acid and an analog thereof for immune system stimulation'20076,632,459'Chlorogenic acid and an analog thereof for immune system stimulation'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2009Based in Ede, NL· patent location history
2008–2013Patents assigned to HOFFMANN LA ROCHE (9)· patent assignee history
2009–2015Based in Odijk, NL· patent location history
2010–2015Patents assigned to GENMAB AS (5)· patent assignee history
2012–2015Patents assigned to GRAUS YVO (6)· patent assignee history
2012–2015Patents assigned to PARREN PAUL (6)· patent assignee history
2012–2015Patents assigned to VAN DE WINKEL JAN (5)· patent assignee history
2015Based in Odjik, NL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 9 | 2008–2013 |
| GRAUS YVOself | 6 | 2012–2015 |
| PARREN PAUL | 6 | 2012–2015 |
| GENMAB AS | 5 | 2010–2015 |
| VAN DE WINKEL JAN | 5 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Odijk, NL | 14 | 2009–2015 |
| Ede, NL | 5 | 2003–2009 |
| Odjik, NL | 1 | 2015 |